Postmenopausal women treated for breast cancer with insulin resistance: clinical, analytical, cross-sectional

Women Health. 2024 Aug;64(7):584-594. doi: 10.1080/03630242.2024.2383289. Epub 2024 Jul 31.

Abstract

This study aims to investigate the potential association between serum levels of cytokines, HSP60, HSP70 and IR (HOMA-IR) in postmenopausal women. We conducted a cross-sectional study involving 381 postmenopausal women, including 94 with a breast cancer diagnosis and 278 without. We analyzed anthropometric and laboratory measurements. Immunoassays were used to measure cytokines (TNF-α, IL-10, and IL-6) as well as heat shock proteins (HSP) 60 and 70 in the serum using the ELISA technique. Women diagnosed with breast cancer showed higher levels of HOMA-IR, IL-6, TNF, and HSP60, and lower levels of IL-10 and HSP70 compared to women without cancer. An association was found between HSP70 and HOMA-IR only in women with breast cancer (β = 0.22, p = .030; without cancer: β = 0.04, p = .404), regardless of age, waist circumference, smoking, and physical activity. No associations were observed between cytokines, HSP60, and HOMA-IR in both groups of women. HSP70 is positively associated with IR in women diagnosed with breast cancer.

Keywords: Breast cancer; HOMA-IR; cardiovascular risk; insulin resistance; postmenopausal.

MeSH terms

  • Aged
  • Breast Neoplasms* / blood
  • Chaperonin 60* / blood
  • Cross-Sectional Studies
  • Cytokines / blood
  • Female
  • HSP70 Heat-Shock Proteins* / blood
  • Humans
  • Insulin Resistance*
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Middle Aged
  • Postmenopause* / blood
  • Tumor Necrosis Factor-alpha / blood

Substances

  • HSP70 Heat-Shock Proteins
  • Chaperonin 60
  • Cytokines
  • Interleukin-6
  • Interleukin-10
  • Tumor Necrosis Factor-alpha